Cas no 95258-11-0 (Yadanzioside F)
Yadanzioside F Chemical and Physical Properties
Names and Identifiers
-
- Picras-1-en-21-oicacid, 15-(acetyloxy)-13,20-epoxy-2-(b-D-glucopyranosyloxy)-11,12-dihydroxy-3,16-dioxo-,methyl ester, (11b,12a,15b)- (9CI)
- Picras-1-en-21-oicacid, 15-(acetyloxy)-13,20-epoxy-2-(b-D-glucopyranosyloxy)-11,12-dihydroxy-3,16-dioxo-,methyl ester, (11b,1
- Yadanzioside F
- methyl acetoxy-dihydroxy-dimethyl-dioxo-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-[?]carboxylate
- BRN 5700475
- Methyl (1R,2S,3R,6R,8S,9S,13S,14R,15R,16S)-3-acetyloxy-15,16-dihydroxy-9,13-dimethyl-4,10-dioxo-11-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-5,18-dioxapentacyclo[12.5.0.01,6.02,17.08,13]nonadec-11-ene-17-carboxylate
- Yadanzioside-F
- DTXSID10915050
- Methyl 15-(acetyloxy)-2-(hexopyranosyloxy)-11,12-dihydroxy-3,16-dioxo-13,20-epoxypicras-1-en-21-oate
- 95258-11-0
- Picras-1-en-21-oic acid, 15-(acetyloxy)-11,12-dihydroxy-3,16-dioxo-13,20-epoxy-2-(beta-D-glucopyranosyloxy)-, methyl ester, (11-beta,12-alpha,15-beta)-
- Methyl 3-acetyloxy-15,16-dihydroxy-9,13-dimethyl-4,10-dioxo-11-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-5,18-dioxapentacyclo[12.5.0.01,6.02,17.08,13]nonadec-11-ene-17-carboxylate
- CS-0104645
- AKOS040762514
- HY-N7190
- Methyl (1R,2S,3R,6R,8S,9S,13S,14R,15R,16S,17S)-3-acetyloxy-15,16-dihydroxy-9,13-dimethyl-4,10-dioxo-11-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-5,18-dioxapentacyclo[12.5.0.01,6.02,17.08,13]nonadec-11-ene-17-carboxylate
- MS-30929
- DA-59204
-
- Inchi： 1S/C29H38O16/c1-9-11-5-14-28-8-41-29(26(39)40-4,22(28)20(24(38)45-14)42-10(2)31)23(37)19(36)21(28)27(11,3)6-12(15(9)32)43-25-18(35)17(34)16(33)13(7-30)44-25/h6,9,11,13-14,16-23,25,30,33-37H,5,7-8H2,1-4H3/t9-,11-,13+,14+,16+,17-,18+,19+,20+,21+,22+,23-,25+,27-,28+,29?/m0/s1
- InChI Key： BYBDRFPMKPUWDZ-TXPSYQKCSA-N
- SMILES： O1C[C@@]23[C@H]4C[C@H]5[C@H](C)C(C(=C[C@]5(C)[C@H]2[C@H]([C@@H](C1(C(=O)OC)[C@@H]3[C@H](C(=O)O4)OC(C)=O)O)O)O[C@H]1[C@@H]([C@H]([C@@H]([C@@H](CO)O1)O)O)O)=O
Computed Properties
- Exact Mass: 642.21600
- Monoisotopic Mass: 642.216
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 6
- Hydrogen Bond Acceptor Count: 16
- Heavy Atom Count: 45
- Rotatable Bond Count: 7
- Complexity: 1320
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 15
- Undefined Atom Stereocenter Count : 1
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Topological Polar Surface Area: 245A^2
- XLogP3: -1.3
Experimental Properties
- Color/Form: Powder
- Density: 1.6±0.1 g/cm3
- Boiling Point: 878.7±65.0 °C at 760 mmHg
- Flash Point: 285.0±27.8 °C
- Refractive Index: 1.639
- PSA: 245.04000
- LogP: -3.31490
- Vapor Pressure: 0.0±0.6 mmHg at 25°C
Yadanzioside F Security Information
- Hazard Statement： H303May be harmful if swallowed+H313Skin contact may be harmful+H333Inhalation may be harmful to the body
- Warning Statement： P264+P280+P305+P351+P338+P337+P313
- Safety Instruction： H303+H313+H333
- Storage Condition：Store at 4 ℃, better at -4 ℃
Yadanzioside F Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| SHANG HAI JI ZHI SHENG HUA Technology Co., Ltd. | Y48920-5 mg |
Picras-1-en-21-oicacid, 15-(acetyloxy)-13,20-epoxy-2-(b-D-glucopyranosyloxy)-11,12-dihydroxy-3,16-dioxo-,methyl ester, (11b,12a,15b)- (9CI) |
95258-11-0 | 5mg |
￥5760.0 | 2021-09-07 | ||
| SHANG HAI TAO SHU Biotechnology Co., Ltd. | TN5266-1 mg |
Yadanzioside F |
95258-11-0 | 1mg |
￥2915.00 | 2022-04-26 | ||
| MedChemExpress | HY-N7190-1mg |
Yadanzioside F |
95258-11-0 | ≥98.0% | 1mg |
￥4000 | 2025-04-15 | |
| TargetMol Chemicals | TN5266-5mg |
Yadanzioside F |
95258-11-0 | 5mg |
￥ 4040 | 2024-07-19 | ||
| TargetMol Chemicals | TN5266-5 mg |
Yadanzioside F |
95258-11-0 | 98% | 5mg |
￥ 4,040 | 2023-07-10 | |
| TargetMol Chemicals | TN5266-1 mL * 10 mM (in DMSO) |
Yadanzioside F |
95258-11-0 | 98% | 1 mL * 10 mM (in DMSO) |
￥ 6150 | 2023-09-15 | |
| SHANG HAI JI ZHI SHENG HUA Technology Co., Ltd. | Y48920-5mg |
Picras-1-en-21-oicacid, 15-(acetyloxy)-13,20-epoxy-2-(b-D-glucopyranosyloxy)-11,12-dihydroxy-3,16-dioxo-,methyl ester, (11b,12a,15b)- (9CI) |
95258-11-0 | ,98.0% | 5mg |
￥5760.0 | 2023-09-05 | |
| TargetMol Chemicals | TN5266-1 ml * 10 mm |
Yadanzioside F |
95258-11-0 | 1 ml * 10 mm |
￥ 6150 | 2024-07-19 |
Yadanzioside F Suppliers
Audited Supplier
Yadanzioside F Related Literature
-
Tao Wang,Yangyang Liu,Yue Deng,Hongbo Fu,Jianmin Chen Environ. Sci.: Nano, 2018,5, 1821-1833
-
Dhirendra K. Chaudhary,Pramendra Kumar,Lokendra Kumar RSC Adv., 2016,6, 94731-94738
-
Brindha J.,Balamurali M. M.,Kaushik Chanda RSC Adv., 2019,9, 34720-34734
-
4. Estimating and correcting interference fringes in infrared spectra in infrared hyperspectral imagingGhazal Azarfar,Ebrahim Aboualizadeh,Nicholas M. Walter,Simona Ratti,Camilla Olivieri,Alessandra Norici,Michael Nasse,Achim Kohler,Mario Giordano Analyst, 2018,143, 4674-4683
-
Eléonore Resongles,Corinne Casiot,Fran?oise Elbaz-Poulichet,Rémi Freydier,Odile Bruneel,Christine Piot,Sophie Delpoux,Aurélie Volant,Angélique Desoeuvre Environ. Sci.: Processes Impacts, 2013,15, 1536-1544
Additional information on Yadanzioside F
Yadanzioside F: A Comprehensive Overview
Yadanzioside F (CAS No. 95258-11-0) is a bioactive compound that has garnered significant attention in the fields of pharmacology and natural product research. This compound, belonging to the class of saponins, is isolated from the roots of *Polygonum multiflorum* Thunb., a traditional Chinese herb known for its medicinal properties. Recent studies have highlighted its potential in various therapeutic applications, making it a subject of intense scientific investigation.
The chemical structure of Yadanzioside F is characterized by a unique glycosylation pattern, which contributes to its bioactivity. Researchers have employed advanced analytical techniques such as high-resolution mass spectrometry (HRMS) and nuclear magnetic resonance (NMR) spectroscopy to elucidate its molecular architecture. These studies have revealed that Yadanzioside F exhibits a complex stereochemistry, which is crucial for its interactions with biological targets.
One of the most promising aspects of Yadanzioside F is its anti-inflammatory activity. Recent in vitro experiments have demonstrated its ability to inhibit pro-inflammatory cytokines such as tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6). This makes it a potential candidate for the development of novel anti-inflammatory agents, particularly for chronic inflammatory diseases such as arthritis and inflammatory bowel disease.
In addition to its anti-inflammatory properties, Yadanzioside F has also shown potent antioxidant activity. Studies have indicated that it can scavenge free radicals and reduce oxidative stress, which are key contributors to various degenerative diseases. This dual action—combining anti-inflammatory and antioxidant effects—positions Yadanzioside F as a versatile compound with broad therapeutic potential.
The pharmacokinetic profile of Yadanzioside F has been extensively studied, revealing favorable absorption and bioavailability characteristics. Preclinical studies in animal models have demonstrated that it can be effectively absorbed through the gastrointestinal tract and distributed to target tissues. These findings are encouraging for the development of oral formulations based on Yadanzioside F.
Recent advancements in computational chemistry have enabled researchers to predict the binding affinity of Yadanzioside F to various drug targets. Molecular docking studies have identified potential interactions with key proteins involved in inflammation and oxidative stress pathways. These insights are invaluable for guiding further experimental validation and optimizing the therapeutic efficacy of Yadanzioside F.
Despite its promising properties, the mechanism of action of Yadanzioside F remains partially understood. Ongoing research aims to elucidate the molecular pathways through which it exerts its effects. Understanding these mechanisms will be critical for harnessing its full therapeutic potential and minimizing off-target effects.
In conclusion, Yadanzioside F (CAS No. 95258-11-0) represents a valuable natural product with significant therapeutic potential. Its anti-inflammatory, antioxidant, and pharmacokinetic properties make it a compelling candidate for drug development. As research continues to uncover its molecular mechanisms and therapeutic applications, Yadanzioside F holds promise as a novel agent in the treatment of chronic inflammatory and oxidative stress-related diseases.
95258-11-0 (Yadanzioside F) Related Products
- 141271-79-6(Bruceoside C)
- 112899-35-1(Picras-2-en-21-oicacid,15-[[(2E)-4-(acetyloxy)-3,4-dimethyl-1-oxo-2-penten-1-yl]oxy]-13,20-epoxy-2-(b-D-glucopyranosyloxy)-11,12-dihydroxy-1,16-dioxo-,methyl ester, (11b,12a,15b)-)
- 141238-29-1(Picras-2-en-1-one, 12-(acetyloxy)-16-(β-D-glucopyranosyloxy)-11,13-dihydroxy-2-methoxy-, (11α,12β,16α)- (9CI))
- 101559-98-2(Picras-3-en-21-oicacid,15-[[(2E)-4-(acetyloxy)-3,4-dimethyl-1-oxo-2-pentenyl]oxy]-13,20-epoxy-3-(b-D-glucopyranosyloxy)-11,12-dihydroxy-2,16-dioxo-,methyl ester, (11b,12a,15b)- (9CI))
- 135638-54-9(Picras-2-en-1-one,13-(acetyloxy)-16-(b-D-glucopyranosyloxy)-2-methoxy-11,12-[methylenebis(oxy)]-, (11a,12b,16a)- (9CI))
- 167782-24-3(Picras-1-en-21-oicacid,15-[[(2E)-4-(acetyloxy)-3,4-dimethyl-1-oxo-2-penten-1-yl]oxy]-13,20-epoxy-2-(b-D-glucopyranosyloxy)-11,12-dihydroxy-3,16-dioxo-,(11b,12a,15b)-)
- 167782-22-1(Picras-1-en-21-oicacid, 13,20-epoxy-2-(b-D-glucopyranosyloxy)-11,12-dihydroxy-15-[(3-methyl-1-oxo-2-butenyl)oxy]-3,16-dioxo-,(11b,12a,15b)- (9CI))
- 167782-23-2(Picras-1-en-21-oicacid, 13,20-epoxy-2-(b-D-glucopyranosyloxy)-11,12-dihydroxy-15-(3-methyl-1-oxobutoxy)-3,16-dioxo-,(11b,12a,15b)-)
- 101560-00-3(Picras-2-en-21-oicacid, 15-[[(2E)-3,4-dimethyl-1-oxo-2-pentenyl]oxy]-13,20-epoxy-2-(b-D-glucopyranosyloxy)-11,12-dihydroxy-1,16-dioxo-,methyl ester, (11b,12a,15b)-)
- 101560-01-4(Yadanzioside N)
